Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Moderate to Severe Chronic Hidradenitis Suppurativa
NCT00918255Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- Apr 2009
- Primary completion
- Mar 2010
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 2 trial of adalimumab in hidradenitis suppurativa (HS), sponsored by Abbott Laboratories. Started Apr 2009; status: completed.
02
Drugs
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on NCT00918255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00918255.